Discovery Laboratories gains on Surfaxin approval

Discovery Laboratories Inc. (NASDAQ:DSCO) gained as much as 44% on Wednesday before closing up 9%, or $0.33, to $4.08 after FDA approved Surfaxin lucinactant late Tuesday to prevent respiratory distre...